• CytomX pens $1.6B Astellas biobucks pact for T-cell R&D

    6 days ago - By Fierce Biotech

    With $80 million upfront and up to $1.6 billion in biobucks, Astellas is still ramping up the biotech deals after ending 2019 on a buyout high.
    Read more ...